UCB SA (UCBJY)
OTCMKTS · Delayed Price · Currency is USD
137.61
-2.40 (-1.71%)
Dec 17, 2025, 4:00 PM EST
UCB SA Market Cap
UCB SA has a market cap or net worth of $52.49 billion as of December 17, 2025. Its market cap has increased by 43.68% in one year.
Market Cap
52.49B
Enterprise Value
53.98B
Revenue
8.04B
Ranking
n/a
PE Ratio
33.55
Stock Price
$137.61
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 52.49B, an increase of 4,271.65%. That is a compound annual growth rate of 13.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 52.49B | 39.04% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | 19.53B | 30.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 723.84M |
| Elite Pharmaceuticals | 534.83M |
| CytoDyn | 383.23M |
| Northwest Biotherapeutics | 376.54M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 311.74M |
| Nika Pharmaceuticals | 285.90M |